In-hospital mortality among hospitalized COVID-19 patients in a tertiary care hospital in Dhaka City: a retrospective cohort study
Age, particularly when combined with chronic conditions like hypertension or chronic kidney disease, is a key predictor of in-hospital COVID-19 mortality. While gender is not an independent risk factor, males tend to have higher mortality rates. Delayed treatment, reflected by shorter hospital stays, also increases risk. Vaccination markedly lowers mortality. In resource-limited settings, lower lobe involvement >50% and TSS ≥ 14 can serve as early triage markers to guide ICU admission or intensified care. These indicators should inform risk assessment tools, resource allocation, and targeted interventions to reduce pandemic-related mortality.
Authors
- Shahnewaz Dewan
- Shagufta Kamal
- Juwel Rana (ORCID: https://orcid.org/0000-0001-5597-664X)
- Gias U. Ahsan (ORCID: https://orcid.org/0000-0003-0737-5940)
- Md Maruf Hasan (ORCID: https://orcid.org/0000-0002-4408-3472)
- Ahmed Hossain (ORCID: https://orcid.org/0000-0003-1566-3993)
Institutions
- Daffodil International University (BD)
- McGill University Health Centre (CA)
- University of Sharjah (AE)
- Showa General Hospital (JP)
- National Institute of Neurosciences & Hospital (BD)
- Institute for Social Transformation (UG)
- National Institute of Cancer Research and Hospital (BD)
- Bangladesh University of Professionals (BD)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-05-20
- DOI
- https://doi.org/10.3389/fmed.2025.1571865
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00